Blog

‘Shark Tank’ Company Simply Good Jars Strikes Deal with Wawa After Sales Soar 1,200%

February 8, 2022

Simply Good Jars is growing rapidly — its sales, its customer base, its physical footprint and its availability. The Philadelphia startup, which appeared on ABC’s “Shark Tank” last March, has seen exponential sales growth of about 1,200% since January 2021, CEO Jared Cannon said. That has allowed his operations to expand and his ambitions to […]

Phenom’s Made its 4th Acquisition in 16 Months as the HR Tech Biz Expands its European Reach

February 4, 2022

In the first half of 2021, HR tech company Phenom announced three acquisitions as it bolstered its business for an inevitable IPO. And here comes the fourth: Today, the Ambler-based company announced it has acquired 2013-founded Tandemploy, a Berlin-based HR tech company focused on solving key problems associated with employee experiences. The addition enhances Phenom’s […]

Philly-Based Robotics Company Burro is Joining John Deere’s Agtech Accelerator

February 2, 2022

When Burro changed its name last year from Augean Robotics, CEO Charlie Andersen said the rebrand fell more in line with iconic agricultural brands that use an animal for their names like Deere and Bobcat. A few months after that name change and a $11 million Series A, Burro will actually be participating in an […]

The Delco Company Where Corporate America’s Old Phones and Computers go to Die

January 31, 2022

CyberCrunch is totally bent on destruction. Its two plants, in Aston and out west in Greensburg, Pa., are places where familiar electronics from Philadelphia’s biggest employers go to die. More precisely, to be shredded into high-tech confetti that data thieves can’t pillage, then sold to recyclers. The more digitized and data-dependent our working lives become, […]

Excision BioTherapeutics Initiates Phase 1/2 Trial Evaluating EBT-101 as a Potential Cure for HIV

January 28, 2022

Excision BioTherapeutics Inc. a clinical-stage biotechnology company developing CRISPR-based therapies intended to cure viral infectious diseases, today announced the initiation of a first-in-human (FIH) Phase 1/2 clinical trial of EBT-101 in individuals living with human immunodeficiency virus type 1 (HIV). The FIH study is a multicenter, open-label, single ascending dose study designed to evaluate the […]